RIGL Stock Analysis: Buy, Sell, or Hold?
RIGL - Rigel Pharmaceuticals Inc. (New)
$38.72
0.43 (1.12%)
▲
5d:
+4.68%
30d:
+28.98%
90d:
+40.8%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
30d
Get Alerted When RIGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: RIGL shows positive signals but monitor for confirmation. Market pricing in 1.2% growth. Moderate conviction.
💡 BUY OPPORTUNITY: RIGL shows positive signals but monitor for confirmation. Market pricing in 1.2% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$72.60
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$45.08
14.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RIGL is currently trading at $38.72, which is considered extended relative to its 30-day fair value range of $29.82 to $36.63. The stock's valuation (Forward PE: 8.1) is in line with its historical norms (7.8). At these levels, the market is pricing in 1.2% annual earnings growth.
Technical Outlook: Technically, RIGL is showing sideways momentum. Immediate support is located at $32.42, while resistance sits at $40.33.
Market Sentiment: RIGL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $54.20 (+40.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RIGL is showing sideways momentum. Immediate support is located at $32.42, while resistance sits at $40.33.
Market Sentiment: RIGL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $54.20 (+40.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$29.82 -
$36.63
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.1%
Protect Your Profits
RIGL is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.7% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 40.0% below Wall St target ($54.20)
- BULLISH: Expecting earnings turnaround to 1.2% growth with 10.3% revenue growth
Trading Range Analysis
30-Day Trading Range
$29.82 -
$36.63
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$3.41
(8.8%)
Support & Resistance Levels
Support Level
$32.42
Resistance Level
$40.33
Current Trend
Sideways
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.10
Wall Street Target
$54.20
(+40.0%)
Revenue Growth (YoY)
10.3%
Earnings Growth (YoY)
-30.2%
Profit Margin
121.5%
Valuation Premium vs History
+1.2% premium
PE vs Historical
8.1 vs 7.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.2%
(market-implied from PE analysis)
1-Year Target
$39.18
(+1%)
2-Year Target
$39.65
(+2%)
3-Year Target
$40.13
(+4%)
3-Yr Target (if PE normalizes)
(PE: 8→8)
PE COMPRESSION
$38.64
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 63.9%)
$351.36
(+807%)
Base:
(SPY PE: 8.1, Growth: 63.9%)
$130.68
(+238%)
Bear:
(PE: 6.9, Growth: 63.9%)
$111.08
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 1.99 | Current EPS (TTM): $19.29
Bull Case
$21.06
(-46%)
Analyst growth -50.0%, PE expands to 2.2
Base Case
$19.15
(-51%)
Market implied -50.0%, PE stable at 2.0
Bear Case
$26.04
(-33%)
Severe decline -20.0%, PE contracts to 1.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 04, 2026 12:20 PM ET
Data refreshes hourly during market hours. Next update: 1:20 PM
Data refreshes hourly during market hours. Next update: 1:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RIGL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Walter H Moos
SELL
4000 shares
2026-02-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$291 | 63 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$46 | 61 BUY |
Advanced RIGL Option Strategies
Professional options setups generated by AI based on today's RIGL price and gamma walls.
